Improved Melatonin Delivery by a Size-Controlled Polydopamine Nanoformulation Attenuates Preclinical Diabetic Retinopathy.
Mol Pharm
; 20(6): 2899-2910, 2023 06 05.
Article
in En
| MEDLINE
| ID: mdl-37116080
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Diabetes Mellitus
/
Diabetic Retinopathy
/
Melatonin
Limits:
Humans
Language:
En
Journal:
Mol Pharm
Journal subject:
BIOLOGIA MOLECULAR
/
FARMACIA
/
FARMACOLOGIA
Year:
2023
Type:
Article
Affiliation country:
India